Our results from all-comers population genetic screening confirmed that rare pLOF variants in BRCA1, BRCA2, PALB2, ATM, and CHEK2 confer significant risk to breast cancer in the overall population.7 The gene discussed is CHEK2; the disease is breast carcinoma.